Clinical Trial Details

EORTC-22922-10925-ROG-BCG

Back to Clinical Trials Database

Phase III randomized trial investigating the role of internal mammary and medial supraclavicular (IM-MS) lymph node chain irradiation in stage I-III breast cancer (Joint study of the EORTC Radiotherapy Cooperative Group and the EORTC Breast Cancer Cooperative Group EORTC 22922/10925)

Study documentation

Trial Status LT-FU ongoing
Dates Date of activation: 23-Jul-1996
Date Step1 close: 15-Jan-2004
Data management at EORTC Yes
Design Phase 3
Randomized open label
Targeted Sample size EORTC Groups: 3780
Treatment Radiotherapy
Study Staff Harry Bartelink (Study Coordinator) , The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis, Amsterdam
Alain Fourquet (Study Coordinator) , Institut Curie- Hopital de Paris, Paris
Philip Poortmans (Study Coordinator) , GasthuisZusters Antwerpen - Sint-Augustinus, Wilrijk
Walter Van den Bogaert (Study Coordinator) , U.Z. Leuven - Campus Gasthuisberg, Leuven
Laura De Meulemeester (Clinical Operations Manager) , EORTC Headquarters, Brussels
Catherine Fortpied (Statistician) , EORTC Headquarters, Brussels
Julie Hermans (Regulatory Affairs Manager) , EORTC Headquarters, Brussels
Bette Stofs (Pharmacovigilance Manager) , EORTC Headquarters, Brussels
Type of cancer Breast
Participating groups EORTC Breast Cancer Group
EORTC Radiation Oncology Group
Centers to be activated AZ Groeninge – Oncology Centre (Kortrijk, Belgium)
Amsterdam UMC - Locatie AMC (Amsterdam, Netherlands)
Assistance Publique - Hopitaux de Paris - CHU Henri Mondor (Creteil, France)
CHU de Grenoble - La Tronche - Hopital A. Michallon (Grenoble, France)
Centre Antoine Lacassagne (Nice, France)
Centre Eugene Marquis (Rennes, France)
Centre Georges-Francois-Leclerc (Dijon, France)
Centre Leon Berard (Lyon, France)
Charite - Universitaetsmedizin Berlin - Campus Mitte (Berlin, Germany)
Cliniques Universitaires Saint-Luc (Brussels, Belgium)
GasthuisZusters Antwerpen - Sint-Augustinus (Wilrijk, Belgium)
Gustave Roussy (Villejuif, France)
Hopital De Jolimont (Haine St Paul, Belgium)
ICO L’Hospitalet - Hospital Duran i Reynals (Institut Catala D'Oncologia) (L' Hospitalet De Llobregat, Spain)
Institut Curie- Hopital de Paris (Paris, France)
Instituut Verbeeten (Tilburg, Netherlands)
Medical University Of Gdansk (Gdansk, Poland)
Medisch Spectrum Twente (Enschede, Netherlands)
Nottingham University Hospitals NHS Trust - City Hospital (Nottingham, United Kingdom)
Ospedale Sant Anna (Como, Italy)
Tergooiziekenhuizen - location Blaricum (Blaricum, Netherlands)
The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis (Amsterdam, Netherlands)
U.Z. Leuven - Campus Gasthuisberg (Leuven, Belgium)
UMC-Academisch Ziekenhuis Utrecht (Utrecht, Netherlands)
Universitaetsklinikum - Essen (Essen, Germany)
Universitaetsklinikum Tuebingen- Crona Kliniken (Tuebingen, Germany)
Protocol summary http://clinicaltrials.gov/ct/show/NCT00002851
NCT number NCT00002851
Financial Support EORTC HQ